A Short History of ENETS
ENETS was established by its founding members to unify neuroendocrine tumor disease research among European medical professionals. Its primary aim was to integrate basic and clinical research with teaching, and to establish guidelines for the diagnosis and therapy of gastroenteropancreatic neuroendocrine tumors (GEP NETs).
Almost 20 years after its foundation, ENETS is now the largest, international NET society with more than 1,500 members.
2004
-
The founding members are (l. to r.): Håkan Ahlman†, Göteborg, Sweden; Bertram Wiedenmann, Berlin, Germany; Ola Nilsson, Göteborg; Barbro Eriksson, Uppsala, Sweden; Kjell Öberg, Uppsala, Sweden; Ursula Plöckinger, Berlin, Germany; Philippe Ruszniewski, Clichy, France; Guido Rindi, Parma, Italy; Martyn Caplin, London, United Kingdom. Founding members not pictured: Rudolf Arnold, Marburg, Germany; Wouter de Herder, Rotterdam, The Netherlands and Gianfranco Delle Fave, Rome, Italy.
- Founding of the European Neuroendocrine Tumor Society in Budapest, Hungary, as an offshoot of the European Neuroendocrine Tumor Network
- 1st Annual ENETS Conference – this conference started a series of cutting-edge conferences attracting more than 1,500 delegates each year
2005
Publication of the first ENETS guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumors
2007
- Revision of the ENETS guidelines along with TNM classifications
- Development of a European NET Registry
2009
- Establishment of an accreditation programme for ENETS Centers of Excellence (CoE) with 6 pilot centers
- Publication of ENETS consensus guidelines for the standard of care for patients with digestive neuroendocrine tumors
2010
- The ENETS Center of Excellence progamme is officially launched
- Publication of ENETS consensus guidelines for the management of patients with rare metastases from digestive neuroendocrine tumors
- The 1st Annual ENETS Postgraduate Course was hosted within the framework of the annual ENETS conference
2012
Publication of updated ENETS consensus guidelines for the diagnosis and treatment of neuroendocrine tumors
2015
Publication of a European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids
2016
Publication of updated consensus guidelines for the diagnosis and treatment of neuroendocrine tumors (update of the guidelines for diagnosis and therapy of NEN from 2012)
2017
- ENETS 2017 consensus guidelines for the diagnosis and treatment of neuroendocrine tumors (standards of care recommendations)
- Meeting with patient advocates (ENETS/INCA meeting) on unmet medical needs in neuroendocrine tumors
2018
Meeting to develop standardised reporting in NEN pathology, imaging, and endoscopy
2020
Covid pandemic - first virtual ENETS conference
2022
- Covid pandemic - first hybrid ENETS conference - in Barcelona, Spain
- ENETS guidance paper for Carcinoid Syndrome and Carcinoid Heart Disease
- Special issue on standardised (synoptic) reporting of neuroendocrine neoplasms
2023
- 20th Annual ENETS Conference - hybrid - in Vienna, Austria
- ENETS guidance paper for digestive neuroendocrine carcinoma
- ENETS guidance paper for gastroduodenal NET G1-G3
- ENETS guidance paper for nonfunctioning pancreatic neuroendocrine tumours
- ENETS guidance paper for appendiceal neuroendocrine tumours
- ENETS guidance paper for functioning pancreatic NET syndromes
- ENETS guidance paper for colorectal neuroendocrine tumours
